|
|
Volumn 27, Issue 8, 2001, Pages 767-780
|
|
Development of a lyophilized parenteral pharmaceutical formulation of the investigational polypeptide marine anticancer agent kahalalide F
|
|
Author keywords
Citric acid monohydrate; Cremophor EL; Glass transition temperature; Kahalalide F; Marine antitumor agent; Parenteral lyophilized formulation; Polypeptide; Polysorbate 80; Sucrose
|
|
Indexed keywords
ALCOHOL;
ANTINEOPLASTIC AGENT;
CITRIC ACID;
CREMOPHOR;
KAHALALIDE F;
MANNITOL;
POLYSORBATE 80;
SODIUM CHLORIDE;
SUCROSE;
UNCLASSIFIED DRUG;
WATER;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CONTROLLED STUDY;
DIFFERENTIAL SCANNING CALORIMETRY;
DRUG FORMULATION;
DRUG SOLUBILITY;
DRUG STABILITY;
DRUG STRUCTURE;
FREEZE DRYING;
INFRARED SPECTROSCOPY;
MOLLUSC;
PROSTATE TUMOR;
ALGORITHMS;
ANTINEOPLASTIC AGENTS;
CALORIMETRY, DIFFERENTIAL SCANNING;
DEPSIPEPTIDES;
DRUG STABILITY;
DRUG STORAGE;
EXCIPIENTS;
FREEZE DRYING;
HUMIDITY;
INFUSIONS, PARENTERAL;
PEPTIDES;
PHARMACEUTICAL SOLUTIONS;
SOLUBILITY;
SPECTROPHOTOMETRY, INFRARED;
SUCROSE;
VEHICLES;
|
|
EID: 0034759073
PISSN: 03639045
EISSN: None
Source Type: Journal
DOI: 10.1081/DDC-100107240 Document Type: Article |
|
Times cited : (16)
|
|
References (22)
|
